Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5274823013 | Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5274824019 | Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Is a | Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has manufactured dose form | Powder for conventional release solution for infusion (dose form) | false | Inferred relationship | Some | ||
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has precise active ingredient | Daunorubicin (substance) | false | Inferred relationship | Some | 1 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has basis of strength substance (attribute) | Daunorubicin (substance) | false | Inferred relationship | Some | 1 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has precise active ingredient | Cytarabine (substance) | false | Inferred relationship | Some | 2 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has basis of strength substance (attribute) | Cytarabine (substance) | false | Inferred relationship | Some | 2 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR